Tumor transcriptome sequencing reveals allelic expression imbalances associated with copy number alterations.

Due to growing throughput and shrinking cost, massively parallel sequencing is rapidly becoming an attractive alternative to microarrays for the genome-wide study of gene expression and copy number alterations in primary tumors. The sequencing of transcripts (RNA-Seq) should offer several advantages...

Full description

Bibliographic Details
Main Authors: Brian B Tuch, Rebecca R Laborde, Xing Xu, Jian Gu, Christina B Chung, Cinna K Monighetti, Sarah J Stanley, Kerry D Olsen, Jan L Kasperbauer, Eric J Moore, Adam J Broomer, Ruoying Tan, Pius M Brzoska, Matthew W Muller, Asim S Siddiqui, Yan W Asmann, Yongming Sun, Scott Kuersten, Melissa A Barker, Francisco M De La Vega, David I Smith
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2010-02-01
Series:PLoS ONE
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/20174472/pdf/?tool=EBI